COMMUNIQUÉS West-GlobeNewswire

-
Arcutis to Host ZORYVE® (Roflumilast) Cream 0.15% FDA Approval Call With KOL
22/07/2024 -
Cell BioEngines Secures an Additional $2 Million in Funding From SOSV and the Empire State Development’s New York Ventures
20/07/2024 -
The Alberta Cancer Foundation’s Enbridge Tour Alberta for Cancer Passes $100 Million Milestone in its 16th Year
20/07/2024 -
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
19/07/2024 -
Aptose Announces Receipt of Deficiency Notice from Nasdaq
19/07/2024 -
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
19/07/2024 -
IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process
19/07/2024 -
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19/07/2024 -
Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
19/07/2024 -
Transparency Notifications from Shareholders
19/07/2024 -
BioSenic S.A. : Transparency notification received from Mr François Rieger
19/07/2024 -
BioSenic S.A. : Notification de transparence reçue de la part de Monsieur François Rieger
19/07/2024 -
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
19/07/2024 -
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
19/07/2024 -
Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
19/07/2024 -
Capra Biosciences Lands $7.5 Million Project Agreement To Demonstrate Platform To Rapidly Scale Pharmaceutical Ingredient Manufacturing
19/07/2024 -
Rakovina Therapeutics Announces Second Upsizing of Private Placement
19/07/2024 -
Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles
19/07/2024 -
Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE
19/07/2024
Pages